Bausch Health Companies Inc.
BHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.01 | 0.06 | -0.04 |
| FCF Yield | 13.13% | 7.69% | 4.09% | 16.48% |
| EV / EBITDA | 35.71 | 29.43 | 37.74 | 26.01 |
| Quality | ||||
| ROIC | 2.25% | 1.75% | 2.25% | 1.17% |
| Gross Margin | 173.25% | 69.80% | 68.97% | 71.59% |
| Cash Conversion Ratio | 2.24 | 2.26 | -2.45 | 6.13 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.11% | 5.69% | 6.09% | 5.81% |
| Free Cash Flow Growth | 65.26% | 97.92% | -80.57% | 44.51% |
| Safety | ||||
| Net Debt / EBITDA | 31.85 | 26.19 | 33.85 | 22.68 |
| Interest Coverage | 0.31 | 0.95 | 0.84 | 1.66 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.46 | 0.43 | 0.46 |
| Cash Conversion Cycle | 321.20 | 199.72 | 210.04 | 191.51 |